Back to Agenda
Session 25: Regulatory Compliance and FDA Inspections: What To Expect After Submitting the NDA
Session Chair(s)
Michael Hamrell, PhD, RAC
President
MORIAH Consultants, United States
- GLP inspections
- GCP inspections
- Inspection outcomes: additional considerations in GCP inspections
- GMP inspections
- Inspection outcomes (GLPs, GCPs, GMPs)
- FDA enforcement actions
- Application Integrity Policy (AIP)
Have an account?